Complement and diseases: defective alternative pathway control results in kidney and eye diseases
Related Experiment Video
Updated: Aug 16, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Peter F Zipfel1, Stefan Heinen, Mihály Józsi
1Department of Infection Biology, Leibniz Institute for Natural Products Research and Infection Biology, Hans Knoell Institute, Beutenbergstr. 11a, 07745 Jena, Germany. peter.zipfel@hki-jena.de
Abstract:
The complement system is a central part of innate immunity and in its normal setting aimed to recognize and eliminate microbes. For elimination toxic activation products are generated locally and are reported directly of the surface of the invading microbe. A deregulation of the alternative pathway results in defective recognition and toxic activation products can be formed on the surface of host tissues and structures. Recent studies have shown that mutated or defective regulators of the alternative pathway of complement are associated with auto immune diseases of the kidney, including the atypical form of hemolytic uremic syndrome (HUS), membranoproliferative glomerulonephritis (MPGN) and also of the eye, such as age-related macular degeneration (ARMD). Current research provides clues how mutations occurring in genes coding for single complement components or the inactivation of single regulators lead to defective alternative pathway amplification, via the convertase C3bBb. These scenarios explain how defects of a single regulator lead to local, organ specific damage.
Insights
Dysregulation of the complement system
Area of Science:
- Immunology
- Complement System Biology
- Innate Immunity
Background:
- The complement system is crucial for innate immunity, targeting microbes.
- Its alternative pathway can malfunction, damaging host tissues.
- Defective regulators are linked to autoimmune kidney and eye diseases.
Purpose of the Study:
- To investigate how complement system dysregulation contributes to autoimmune diseases.
- To explore the role of alternative pathway defects in organ-specific damage.
Main Methods:
- Analysis of genetic mutations in complement regulators.
- Studying the alternative pathway amplification via C3bBb convertase.
- Correlating genetic defects with clinical manifestations of HUS, MPGN, and ARMD.
Main Results:
- Mutations in complement regulators cause defective alternative pathway amplification.
- This defect leads to the formation of toxic products on host tissues.
- Specific genetic defects are associated with kidney diseases like atypical HUS and MPGN, and eye conditions like ARMD.
Conclusions:
- Defects in single complement regulators can trigger local, organ-specific autoimmune damage.
- Understanding these mechanisms is key to treating complement-mediated diseases.
- Targeting the alternative pathway offers potential therapeutic strategies.
Related Concept Videos
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Complement System
Complementation Tests
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Genetic Lingo
Photoreceptors and Visual Pathways
Nephrons

